NYSE:NRZ

New Residential Investment Price Target, Predictions & Analyst Ratings

$9.55

-0.08 (-0.83%)

(As of 07/6/2022 09:52 AM ET)

Add

Compare

Today's Range: $9.55
▼
$9.79
50-Day Range: $8.25
▼
$11.74
52-Week Range: $8.18
▼
$11.81

Volume: 33,695 shs
Average Volume: 8.39 million shs
Market Capitalization: $4.46 billion

P/E Ratio: 4.23
Dividend Yield: 10.47%
Price Target: $12.20

New Residential Investment (NYSE:NRZ) Price Target and Consensus Rating (2022)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Analyst Rating

Moderate Buy
Based on 7 Analyst Ratings

Consensus Analyst Price Target

$12.20
27.75% Upside

High Prediction	$13.50
Average Prediction	$12.20
Low Prediction	$10.00

Type	Current 7/6/21 to 7/6/22	1 Month Ago 6/6/21 to 6/6/22	3 Months Ago 4/7/21 to 4/7/22	1 Year Ago 7/6/20 to 7/6/21
Consensus Rating	Moderate Buy	Moderate Buy	Moderate Buy	Moderate Buy
Strong Buy	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	6 Buy rating(s)	6 Buy rating(s)	8 Buy rating(s)	13 Buy rating(s)
Hold	0 Hold rating(s)	1 Hold rating(s)	1 Hold rating(s)	1 Hold rating(s)
Sell	1 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)
Consensus Price Target	$12.20	$12.60	$12.67	$11.50
Predicted Upside	27.75% Upside	12.84% Upside	16.05% Upside	19.90% Upside

Get New Residential Investment Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for NRZ and its competitors with MarketBeat's FREE daily newsletter.

NRZ Stock Analyst Ratings By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

NRZ Stock Price Target by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

New Residential Investment Stock vs. The Competition

Type	New Residential Investment	Finance Companies	S&P 500
Consensus Rating Score	2.71	2.52	2.51
Consensus Rating	Moderate Buy	Buy	Buy
Predicted Upside	26.69% Upside	72.83% Upside	31.80% Upside
News Sentiment Rating	Neutral News	Positive News	Neutral News
MarketBeat Community Rating	Outperform Votes 548 74.05% Underperform Votes 192 25.95%	Avg. Outperform Votes 150 62.76% Avg. Underperform Votes 89 37.24%	Avg. Outperform Votes 840 69.08% Avg. Underperform Votes 376 30.92%

Historical New Residential Investment Price Targets and Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Export to Excel

Date	Brokerage	Analyst Name	Action	Rating	Price Target	Upside/Downside on Report Date
6/13/2022	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating		Downgrade	Neutral ➝ Underweight	$12.00 ➝ $10.00	-8.00%
3/29/2022	Raymond James Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Outperform	$13.00 ➝ $13.50	+24.88%
11/19/2021	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Outperform	$12.00 ➝ $13.00	+16.49%
10/18/2021	JMP Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Market Outperform	$11.00 ➝ $11.50	+1.23%
10/8/2021	Wedbush Subscribe to MarketBeat All Access for the recommendation accuracy rating	H. Coffey Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Outperform
9/29/2021	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Overweight
8/30/2021	Credit Suisse Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Outperform	$12.00 ➝ $13.00	+20.82%
4/21/2021	Jonestrading Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Buy ➝ Hold
4/16/2021	BTIG Research Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy	$12.00 ➝ $13.00	+24.76%
12/18/2020	Keefe, Bruyette & Woods Subscribe to MarketBeat All Access for the recommendation accuracy rating		Upgrade	Market Perform ➝ Outperform	$10.50	+4.58%

12/14/2020	Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Buy	$11.00	+18.15%
11/24/2020	B. Riley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Timothy P. Hayes Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Target	Buy	$9.50 ➝ $11.50	+15.58%
11/6/2020	Wolfe Research Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Outperform
10/20/2020	Compass Point Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Buy	$11.00	+36.65%
9/24/2020	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Buy	$11.00	+47.45%
7/27/2020	Argus Subscribe to MarketBeat All Access for the recommendation accuracy rating	Kevin Heal Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Hold ➝ Buy	$10.00	+31.41%
2/13/2020	Nomura Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy	$18.50 ➝ $20.00	+14.55%
11/14/2019	Piper Jaffray Companies Subscribe to MarketBeat All Access for the recommendation accuracy rating		Downgrade	Overweight ➝ Neutral	$16.00	-0.31%

(Data available from 7/6/2017 forward. View 10+ years of historical ratings with our analyst ratings screener.)

New Residential Investment Price Target - Frequently Asked Questions

What is New Residential Investment's consensus rating and price target?: According to the issued ratings of 7 analysts in the last year, the consensus rating for New Residential Investment stock is Moderate Buy based on the current 1 sell rating and 6 buy ratings for NRZ. The average twelve-month price prediction for New Residential Investment is $12.20 with a high price target of $13.50 and a low price target of $10.00. Learn more on NRZ's analyst rating history.
Do Wall Street analysts like New Residential Investment more than its competitors?: Analysts like New Residential Investment stock more than the stock of other Finance companies. The consensus rating for New Residential Investment is Moderate Buy while the average consensus rating for finance companies is Buy. Learn more on how NRZ compares to other companies.
Do MarketBeat users like New Residential Investment more than its competitors?: MarketBeat users like New Residential Investment stock more than the stock of other Finance companies. 74.05% of MarketBeat users gave New Residential Investment an outperform vote while finance companies recieve an average of 62.76% outperform votes by MarketBeat users.

Is New Residential Investment being downgraded by Wall Street analysts?: Over the previous 90 days, New Residential Investment's stock had 2 downgrades by analysts.
Does New Residential Investment's stock price have much upside?: According to analysts, New Residential Investment's stock has a predicted upside of 10.99% based on their 12-month price targets.
What analysts cover New Residential Investment?: New Residential Investment has been rated by Piper Sandler in the past 90 days.

This page (NYSE:NRZ) was last updated on 7/6/2022 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms